Bloomberg reported Tuesday that Mirati Therapeutics is once again the subject of takeover talks, reviving similar rumors from a year ago. In fact, Mirati has been considering strategic options “for some time,” according to the latest reports.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,